These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22116772)

  • 1. Concerning the analysis of unbiased histopathology data.
    Levin S
    Toxicol Pathol; 2011 Dec; 39(7):1139. PubMed ID: 22116772
    [No Abstract]   [Full Text] [Related]  

  • 2. Counterpoint to "Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe to treatment?)".
    Wolf JC
    Toxicol Pathol; 2011 Oct; 39(6):1017-9. PubMed ID: 21971936
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Letter to Editor by Dr. J. C. Wolf on "Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe it to treatment?)".
    Holland T; Holland C
    Toxicol Pathol; 2011 Dec; 39(7):1138. PubMed ID: 22224209
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe it to treatment?).
    Holland T; Holland C
    Toxicol Pathol; 2011 Jun; 39(4):569-75. PubMed ID: 21558466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative power of the discriminant methods used in toxicological pathology.
    Holland T
    Toxicol Pathol; 2005; 33(4):490-4. PubMed ID: 16036867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unbiased histological examinations in toxicological experiments (or, the informed leading the blinded examination).
    Holland T; Holland C
    Toxicol Pathol; 2011 Jun; 39(4):711-4. PubMed ID: 21540173
    [No Abstract]   [Full Text] [Related]  

  • 7. True prediction of lowest observed adverse effect levels.
    García-Domenech R; de Julián-Ortiz JV; Besalú E
    Mol Divers; 2006 May; 10(2):159-68. PubMed ID: 16721628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Society of Toxicologic Pathology position paper on best practices on recovery studies: the role of the anatomic pathologist.
    Perry R; Farris G; Bienvenu JG; Dean C; Foley G; Mahrt C; Short B;
    Toxicol Pathol; 2013; 41(8):1159-69. PubMed ID: 23531793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings of the sixteenth international workshop on in vitro toxicology.
    Blaauboer BJ; Scarino ML; van der Valk J
    Toxicol In Vitro; 2011 Sep; 25(6):1161. PubMed ID: 21693177
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of the Thirteenth International Workshop on In Vitro Toxicology. September 8-11, 2004. Zegrze, Poland.
    Toxicol In Vitro; 2005 Oct; 19(7):843-1013. PubMed ID: 17089451
    [No Abstract]   [Full Text] [Related]  

  • 11. A survey of discriminant methods used in toxicological histopathology.
    Holland T
    Toxicol Pathol; 2001; 29(2):269-73. PubMed ID: 11421496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement and estimation of electrophilic reactivity for predictive toxicology.
    Schwöbel JA; Koleva YK; Enoch SJ; Bajot F; Hewitt M; Madden JC; Roberts DW; Schultz TW; Cronin MT
    Chem Rev; 2011 Apr; 111(4):2562-96. PubMed ID: 21401043
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary: regulatory toxicology and the critical path: predicting long-term outcomes from short-term studies.
    Jacobson-Kram D
    Vet Pathol; 2008 Sep; 45(5):707-9. PubMed ID: 18725478
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicology and stem cells: New frontiers.
    Caloni F; Ferrari M; De Angelis I
    ALTEX; 2014; 31(1):94. PubMed ID: 24448761
    [No Abstract]   [Full Text] [Related]  

  • 15. Opinion on Current Use of Non-Blinded Versus Blinded Histopathologic Evaluation in Animal Toxicity Studies.
    Bolon B; Caverly Rae JM; Colman K; Francke S; Jensen K; Keane K; McInnes EF; Nakano-Ito K; Perry R; Polack E; Regan KS; Romeike A; Young JK; Galbreath EJ
    Toxicol Pathol; 2020 Jun; 48(4):549-559. PubMed ID: 32347786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graphical display of histopathology data from toxicology studies for drug discovery and development: An industry perspective.
    Brown AP; Drew P; Knight B; Marc P; Troth S; Wuersch K; Zandee J
    Regul Toxicol Pharmacol; 2016 Dec; 82():167-172. PubMed ID: 27769829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [INVITOX 2002: 12th International workshop on in vitro toxicology].
    Boess F; Scholz G; Spielman H
    ALTEX; 2003; 20(1):36-9. PubMed ID: 12674101
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
    von Aulock S
    ALTEX; 2013; 30(1):1. PubMed ID: 23451363
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings of the 17th ESTIV congress 2012.
    Vinken M; Scarino ML; Roggen E; Blaauboer BJ
    Toxicol In Vitro; 2014 Feb; 28(1):1-2. PubMed ID: 24184332
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicology is IN: in silico, in vitro, integrated testing strategy.
    Caloni F; Benfenati E; Sambuy Y
    ALTEX; 2016; 33(2):187-8. PubMed ID: 27032091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.